iSpecimen (ISPC) Income from Non-Controlling Interests (2022 - 2023)

iSpecimen (ISPC) recorded quarterly Income from Non-Controlling Interests of $2.1 million in Q3 2023, down 39.71% quarter-over-quarter from $3.5 million in Q2 2023, and down 31.8% on a YoY basis from $3.1 million in Q3 2022.

iSpecimen (ISPC) Income from Non-Controlling Interests (2022 - 2023) Analysis & Trends

iSpecimen's Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at $2.1 million for Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn -
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn 5.00 Mn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn -
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn -
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn -
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn 1.00 Mn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn -
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn -
10 iSpecimen 1.02 Mn -1.79 Mn -1.39 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 2.11 Mn
Jun 30, 2023 3.50 Mn
Mar 31, 2023 2.41 Mn
Sep 30, 2022 3.10 Mn
Jun 30, 2022 2.61 Mn
Mar 31, 2022 2.38 Mn